Type I IFN ??? A blunt spear in fighting HIV-1 infection, Cytokine & Growth Factor Reviews, vol.26, issue.2, pp.143-158 ,
DOI : 10.1016/j.cytogfr.2014.10.004
Interferons at age 50: past, current and future impact on biomedicine, Nature Reviews Drug Discovery, vol.56, issue.12, pp.975-990, 2007. ,
DOI : 10.4049/jimmunol.178.12.7540
URL : https://hal.archives-ouvertes.fr/hal-00203077
Chronic viral hepatitis: epidemiology, molecular biology, and antiviral therapy, Frontiers in Bioscience, vol.16, issue.1, pp.225-250, 2011. ,
DOI : 10.2741/3685
Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression Interferon-?, immune activation and immune dysfunction in treated HIV infection, CrossRef] [PubMed] 7. Cha, pp.601-605, 2014. ,
Interferon-? is the primary plasma type-I IFN in HIV-1 infection and correlates with immune activation and disease markers Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection, PLoS ONEJ. Nat. Med, vol.8, issue.16, pp.452-459, 2010. ,
Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction, Nature Medicine, vol.168, issue.10, pp.1198-1202, 2006. ,
DOI : 10.4049/jimmunol.168.6.3099
Programmed death 1: a critical regulator of T-cell function and a strong target for immunotherapies for chronic viral infections, Current Opinion in HIV and AIDS, vol.2, issue.3, pp.219-227, 2007. ,
DOI : 10.1097/COH.0b013e3280ebb5c9
Foxo3a: An integrator of immune dysfunction during HIV infection, Cytokine & Growth Factor Reviews, vol.23, issue.4-5, pp.215-221, 2012. ,
DOI : 10.1016/j.cytogfr.2012.05.008
Loss of memory B cells during chronic HIV infection is driven by Foxo3a- and TRAIL-mediated apoptosis, Journal of Clinical Investigation, vol.121, issue.10, pp.3877-3888, 2011. ,
DOI : 10.1172/JCI59211DS1
Transcription factor FOXO3a controls the persistence of memory CD4+ T cells during HIV infection, Nature Medicine, vol.382, issue.3, pp.266-274, 2008. ,
DOI : 10.4049/jimmunol.174.8.4753
Cytokines and persistent viral infections, Cytokine, vol.82, pp.4-15, 2016. ,
DOI : 10.1016/j.cyto.2016.02.006
The Blood Transcriptional Signature of Chronic Hepatitis C Virus Is Consistent with an Ongoing Interferon-Mediated Antiviral Response, Journal of Interferon & Cytokine Research, vol.33, issue.1, pp.15-23, 2013. ,
DOI : 10.1089/jir.2012.0037
Type I Interferon: Understanding Its Role in HIV Pathogenesis and Therapy, Current HIV/AIDS Reports, vol.169, issue.6, pp.41-53, 2015. ,
DOI : 10.1093/infdis/169.6.1351
Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs, Journal of Clinical Investigation, vol.127, issue.1, pp.269-279, 2017. ,
DOI : 10.1172/JCI90745DS1
URL : http://europepmc.org/articles/pmc5199717?pdf=render
Type I interferons suppress viral replication but contribute to T cell depletion and dysfunction during chronic HIV-1 infection, JCI Insight, vol.2, issue.12, p.94366, 2017. ,
DOI : 10.1172/jci.insight.94366DS1
CD4+ T-Cell Deficiency in HIV Patients Responding to Antiretroviral Therapy Is Associated With Increased Expression of Interferon-Stimulated Genes in CD4+ T Cells, The Journal of Infectious Diseases, vol.203, issue.12, pp.1927-1935, 2011. ,
DOI : 10.1093/infdis/jir060
IMMUNOBIOLOGY AND PATHOGENESIS OF VIRAL HEPATITIS, Annual Review of Pathology: Mechanisms of Disease, vol.1, issue.1, pp.23-61, 2006. ,
DOI : 10.1146/annurev.pathol.1.110304.100230
Desensitization to type I interferon in HIV-1 infection correlates with markers of immune activation and disease progression, Blood, vol.113, issue.22, pp.5497-5505, 2009. ,
DOI : 10.1182/blood-2008-11-190231
Immunoactivation induced by chronic viral infection inhibits viral replication and drives immunosuppression through sustained IFN-I responses, European Journal of Immunology, vol.14, issue.2, pp.372-380, 2016. ,
DOI : 10.1038/nm1780
URL : http://onlinelibrary.wiley.com/doi/10.1002/eji.201545765/pdf
HIV-1, interferon and the interferon regulatory factor system: An interplay between induction, antiviral responses and viral evasion, Cytokine & Growth Factor Reviews, vol.23, issue.4-5, pp.255-270, 2012. ,
DOI : 10.1016/j.cytogfr.2012.06.001
Genomic analysis of the host response to hepatitis C virus infection, Proc. Natl. Acad. Sci. USA 2002, pp.15669-15674 ,
Persistent LCMV Infection Is Controlled by Blockade of Type I Interferon Signaling, Science, vol.69, issue.2, pp.207-211, 2013. ,
DOI : 10.1146/annurev.pathol.1.110304.100230
The Significance of Type-I Interferons in the Pathogenesis and Therapy of Human Immunodeficiency Virus 1 Infection, Frontiers in Immunology, vol.1, p.1431, 2017. ,
DOI : 10.1126/sciimmunol.aah3565
Decoding the complexity of type I interferon to treat persistent viral infections, Trends in Microbiology, vol.21, issue.12, pp.634-640, 2013. ,
DOI : 10.1016/j.tim.2013.10.003
Blockade of Chronic Type I Interferon Signaling to Control Persistent LCMV Infection, Science, vol.22, issue.2, pp.202-207, 2013. ,
DOI : 10.1016/j.immuni.2005.01.005
Downregulation of Robust Acute Type I Interferon Responses Distinguishes Nonpathogenic Simian Immunodeficiency Virus (SIV) Infection of Natural Hosts from Pathogenic SIV Infection of Rhesus Macaques, Journal of Virology, vol.84, issue.15, pp.7886-7891, 2010. ,
DOI : 10.1128/JVI.02612-09
Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response, Journal of Clinical Investigation, vol.119, pp.3544-3555, 2009. ,
DOI : 10.1172/JCI40093DS1
Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections, Nature Medicine, vol.72, issue.10, pp.1077-1087, 2008. ,
DOI : 10.4049/jimmunol.179.5.3035
Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque, Journal of Clinical Investigation, vol.121, issue.6, pp.2391-2400, 2011. ,
DOI : 10.1172/JCI45235DS1
Chronic innate immune activation as a cause of HIV-1 immunopathogenesis, Clinical Immunology, vol.126, issue.3, pp.235-242, 2008. ,
DOI : 10.1016/j.clim.2007.08.015
Chronic CD4+ T-Cell Activation and Depletion in Human Immunodeficiency Virus Type 1 Infection: Type I Interferon-Mediated Disruption of T-Cell Dynamics, Journal of Virology, vol.82, issue.4, pp.1870-1883, 2008. ,
DOI : 10.1128/JVI.02228-07
Interferons and interferon (IFN)-inducible protein 10 during highly active anti-retroviral therapy (HAART)-possible immunosuppressive role of IFN-alpha in HIV infection, Clinical and Experimental Immunology, vol.13, issue.3, pp.479-485, 2000. ,
DOI : 10.1093/infdis/169.5.981
Lymph node architecture collapse and consequent modulation of FOXO3a pathway on memory T- and B-cells during HIV infection, Seminars in Immunology, vol.20, issue.3, pp.196-203, 2008. ,
DOI : 10.1016/j.smim.2008.07.008
Targeting type I interferon???mediated activation restores immune function in chronic HIV infection, Journal of Clinical Investigation, vol.127, issue.1, pp.260-268, 2017. ,
DOI : 10.1172/JCI89488DS1
URL : http://europepmc.org/articles/pmc5199686?pdf=render
Safety and pharmacodynamics of rontalizumab in patients with systemic lupus erythematosus: Results of a phase I, placebo-controlled, double-blind, dose-escalation study, Arthritis & Rheumatism, vol.10, issue.Suppl 1, pp.3666-3676, 2012. ,
DOI : 10.1186/ar2559
Pharmacogenomics and Translational Simulations to Bridge Indications for an Anti-Interferon-?? Receptor Antibody, Clinical Pharmacology & Therapeutics, vol.79, issue.6, pp.483-492, 2013. ,
DOI : 10.1016/j.cmpb.2005.04.005
Interfering with type I Interferon: A novel approach to purge persistent viral infection, Cell Cycle, vol.11, issue.18, pp.2919-2920, 2013. ,
DOI : 10.1016/j.chom.2012.03.009
URL : http://www.tandfonline.com/doi/pdf/10.4161/cc.26175?needAccess=true
Differential expression of IFN-?? and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients, Proc. Natl. Acad. Sci, pp.7000-7005, 2006. ,
DOI : 10.1002/1097-0320(20010901)45:1<37::AID-CYTO1142>3.0.CO;2-E
Increased Interferon Alpha Expression in Circulating Plasmacytoid Dendritic Cells of HIV-1-Infected Patients, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.48, issue.5, pp.522-530, 2008. ,
DOI : 10.1097/QAI.0b013e31817f97cf
HIV-antibody complexes enhance production of type I interferon by plasmacytoid dendritic cells, J. Clin. Investig, vol.127, pp.4352-4364, 2017. ,
Type I interferon negatively controls plasmacytoid dendritic cell numbers in vivo, The Journal of Experimental Medicine, vol.208, issue.12, pp.2367-2374, 2011. ,
DOI : 10.1016/j.chom.2008.08.016
URL : http://jem.rupress.org/content/jem/208/12/2367.full.pdf
PDL-1 upregulation on monocytes and T cells by HIV via type I interferon: Restricted expression of type I interferon receptor by CCR5-expressing leukocytes, Clinical Immunology, vol.129, issue.1, pp.132-144, 2008. ,
DOI : 10.1016/j.clim.2008.05.009
IFN-??-Induced Downregulation of miR-221 in Dendritic Cells: Implications for HCV Pathogenesis and Treatment, Journal of Interferon & Cytokine Research, vol.35, issue.9, pp.698-709, 2015. ,
DOI : 10.1089/jir.2014.0211
Type I and Type II Interferon Coordinately Regulate Suppressive Dendritic Cell Fate and Function during Viral Persistence, PLOS Pathogens, vol.41, issue.Web Server issue, p.1005356, 2016. ,
DOI : 10.1371/journal.ppat.1005356.s003
URL : https://doi.org/10.1371/journal.ppat.1005356
Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus, Nature Immunology, vol.150, issue.1, pp.51-57, 2011. ,
DOI : 10.1073/pnas.89.1.314
Chronic but Not Acute Virus Infection Induces Sustained Expansion of Myeloid Suppressor Cell Numbers that Inhibit Viral-Specific T Cell Immunity, Immunity, vol.38, issue.2, pp.309-321, 2013. ,
DOI : 10.1016/j.immuni.2012.10.022
Chronic Type I IFN Is Sufficient To Promote Immunosuppression through Accumulation of Myeloid-Derived Suppressor Cells, The Journal of Immunology, vol.69, issue.3 ,
DOI : 10.1093/infdis/jis663
Interferon-?? drives monocyte gene expression in chronic unsuppressed HIV-1 infection, AIDS, vol.24, issue.10, pp.1415-1423, 2010. ,
DOI : 10.1097/QAD.0b013e32833ac623
CD4+ T-cell death induced by infectious and noninfectious HIV-1: role of type 1 interferon-dependent, TRAIL/DR5-mediated apoptosis, Blood, vol.106, issue.10, pp.3524-3531, 2005. ,
DOI : 10.1182/blood-2005-03-1243
Abnormal B cell memory subsets dominate HIV-specific responses in infected individuals, Journal of Clinical Investigation, vol.124, issue.7, pp.3252-3262, 2014. ,
DOI : 10.1172/JCI74351DS1
Insights into B cells and HIV-specific B-cell responses in HIV-infected individuals, Immunological Reviews, vol.301, issue.Suppl, pp.207-224, 2013. ,
DOI : 10.1126/science.1086907
Type I interferon suppresses virus-specific B cell responses by modulating CD8+ T cell differentiation ,
Regulation of TNF-related apoptosis-inducing ligand on primary CD4+ T cells by HIV-1: Role of type I IFN-producing plasmacytoid dendritic cells, Proc. Natl. Acad. Sci. USA 2005, pp.13974-13979 ,
DOI : 10.1128/JVI.79.7.4043-4054.2005
T Cell Numbers in Treated HIV Infection, The Journal of Immunology, vol.193, issue.5, pp.2178-2186, 2014. ,
DOI : 10.4049/jimmunol.1302536
B-cell responses to HIV infection, Immunological Reviews, vol.10, issue.1676-1685, pp.33-48 ,
DOI : 10.1186/1742-4690-10-117
URL : http://europepmc.org/articles/pmc5300048?pdf=render
B-cell abnormalities and impact on antibody response in HIV infection, Current Opinion in HIV and AIDS, vol.12, issue.3, pp.203-208 ,
DOI : 10.1097/COH.0000000000000359
Type I Interferon Impairs Specific Antibody Responses Early during Establishment of LCMV Infection, Frontiers in Immunology, vol.189, issue.11, p.564, 2016. ,
DOI : 10.1084/jem.189.11.1791
URL : https://hal.archives-ouvertes.fr/pasteur-01535181
Current topics in HIV pathogenesis, part 2: Inflammation drives a Warburg-like effect on the metabolism of HIV-infected subjects, Cytokine & Growth Factor Reviews, vol.28, pp.1-10, 2016. ,
DOI : 10.1016/j.cytogfr.2016.01.001
URL : https://hal.archives-ouvertes.fr/pasteur-01350802
T-cell exhaustion in HIV infection, HIV infection, pp.13-19, 2008. ,
DOI : 10.4049/jimmunol.173.2.945
et al. Type I interferon upregulates bak and contributes to T cell loss during human immunodeficiency virus (HIV) infection, PLoS Pathog, vol.2013, issue.9, p.1003658 ,
Chronic Exposure to Type-I IFN under Lymphopenic Conditions Alters CD4 T Cell Homeostasis, PLoS Pathogens, vol.7, issue.3, p.1003976, 2014. ,
DOI : 10.1371/journal.ppat.1003976.s008
HIV-Induced Type I Interferon and Tryptophan Catabolism Drive T Cell Dysfunction Despite Phenotypic Activation, PLoS ONE, vol.72, issue.8, p.2961, 2008. ,
DOI : 10.1371/journal.pone.0002961.s001
URL : https://doi.org/10.1371/journal.pone.0002961
B and T Lymphocyte Attenuator Down-regulation by HIV-1 Depends on Type I Interferon and Contributes to T-Cell Hyperactivation, The Journal of Infectious Diseases, vol.15, issue.11, pp.1668-1678, 2011. ,
DOI : 10.1038/nm.2004
Molecular and Transcriptional Basis of CD4+ T Cell Dysfunction during Chronic Infection, Immunity, vol.40, issue.2, pp.289-302, 2014. ,
DOI : 10.1016/j.immuni.2014.01.005
Type I interferon suppresses de novo virus-specific CD4 Th1 immunity during an established persistent viral infection, Proc. Natl. Acad. Sci. USA 2014, pp.7409-7414 ,
DOI : 10.1172/JCI26856
URL : http://www.pnas.org/content/111/20/7409.full.pdf
ABSTRACT, Journal of Virology, vol.89, issue.4, pp.2112-2120, 2015. ,
DOI : 10.1128/JVI.02245-14
Type I interferons directly inhibit regulatory T cells to allow optimal antiviral T cell responses during acute LCMV infection, The Journal of Experimental Medicine, vol.161, issue.5, pp.961-974, 2014. ,
DOI : 10.1084/jem.20110236
URL : http://jem.rupress.org/content/jem/211/5/961.full.pdf
Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection, The Journal of Experimental Medicine, vol.68, issue.9, 1905. ,
DOI : 10.1038/nri1806
Timing and Magnitude of Type I Interferon Responses by Distinct Sensors Impact CD8??T Cell Exhaustion and Chronic Viral Infection, Cell Host & Microbe, vol.11, issue.6, pp.631-642, 2012. ,
DOI : 10.1016/j.chom.2012.05.003